Janney Montgomery Scott LLC Spero Therapeutics, Inc. Transaction History

Janney Montgomery Scott LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.74 - $7.44 $18,870 - $189,720	-25,500 Closed	0 $0
Q4 2021 Jan 27, 2022	SELL	$13.09 - $18.77 $6,545 - $9,385	-500 Reduced 1.92%	25,500 $408,000
Q3 2021 Oct 29, 2021	BUY	$13.03 - $19.51 $32,575 - $48,775	2,500 Added 10.64%	26,000 $479,000
Q2 2021 Jul 26, 2021	BUY	$12.22 - $15.79 $103,870 - $134,215	8,500 Added 56.67%	23,500 $328,000
Q1 2021 Apr 27, 2021	BUY	$13.23 - $21.48 $39,690 - $64,440	3,000 Added 25.0%	15,000 $221,000
Q4 2020 Jan 25, 2021	SELL	$11.65 - $22.07 $29,125 - $55,175	-2,500 Reduced 17.24%	12,000 $233,000
Q1 2020 Apr 30, 2020	BUY	$5.27 - $10.41 $5,270 - $10,410	1,000 Added 7.41%	14,500 $117,000
Q4 2019 Jan 21, 2020	BUY	$9.46 - $12.16 $127,710 - $164,160	13,500 New	13,500 $130,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.7M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.